Clinical Trials
Tonix is committed to improving the lives of patients by identifying, researching and developing promising therapies which have the potential to address unmet needs.
TNX-1300
Phase II – Cocaine Intoxication
A Phase 2 single-blind, randomized, multicenter study to compare the efficacy and safety of a single dose of TNX-1300 to placebo with usual care in patients with acute cocaine intoxication within the emergency department setting.
For more information, please visit: clinicaltrials.gov (NCT06045793)
Patient Resources
The below are a few patient advocacy organizations that provide resources and support to those affected by Fibromyalgia: